Send feedback

MAP4 p.Val549=

c.1647C>T · rs146972984 · VCV3035749

Likely benign No assertion criteria
Classification
Likely benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
rare (popmax 0.193%, afr)
Conditions
1
MAP4-related disorder

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.35GERP -2.9
Overall
CADD0.772PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.193% African / African-American · 145/75,032 alleles
Filtering AF 0.168% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.158%
Overall 0.00979% 158/1,614,156 alleles · rare exomes 78/1,461,890 · genomes 80/152,266 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.193% 517
Admixed American 0.0117% 8,573
Remaining individualsnot grpmax-eligible 0.0096% 10,418

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MAP4
Protein
p.Val549=
Coding
c.1647C>T
MANE Select
NM_001385682
dbSNP
rs146972984
Type
single nucleotide variant
Location
chr3:47916180 (GRCh38)
Gene constraint
LOEUF 0.512 · pLI 0.14 (gnomAD)
Structure
AlphaFold pLDDT 43.03
Full MAP4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

MAP4-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map4-p-val549 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown